Coming soon: mRNA Vector Analytics Masterclass

Lipid nanoparticle carrying mRNA
Vector Analytics Masterclass kicks off March 15th

In recent years, we’ve seen how advances in nanotechnology and nucleic acid chemistry have filled up pharmaceutical pipelines to address previously untreatable diseases. Viral and non-viral delivery vectors are helping to turn nucleic acids into vaccines that protect communities and therapies that can transform lives.

These vectors show great promise; however, they pose significant manufacturing and analytical challenges compared to more established drugs. Consequently, there is a need to improve our understanding of:

  • how to best characterize these vectors using fit-for-purpose technology
  • what analytical tools can tell us about these samples during product development, process control and quality control.

Top tips for characterizing lipid nanoparticles (LNPs)

To help you overcome these challenges, we’re hosting a Vector Analytics Masterclass. This 6-part webinar series will kick off on 15 March with my session, Top tips for characterizing lipid nanoparticles (LNPs)

Join me to review a range of complementary, label-free biophysical techniques that you can apply to characterize the physical and chemical attributes of liquid nanoparticles (LNP) encapsulating mRNA.

Discover the series

Every month, one of in-house characterization experts will dive deep into the methodologies you need for successful vector development. They’ll also show you how to generate robust measurement and help you understand how a holistic approach to generating data analysis will give you greater confidence in your results.

Here’s what you can expect from the Vector Analytics Masterclass series:

Want in?

You can register for the first webinar in the Vector Analytics Masterclass series by clicking on the links above. Registration for the subsequent installments will open soon. 

Further reading

In December we published the peer-reviewed paper, Biophysical characterization of viral and lipid-based vectorsread it here >>

Explore our solutions for vaccine and non-viral vector characterization here >>

Explore our solutions for viral vector characterization here >>